1-Boc-4-(2-Aminoethyl)-4-hydroxypiperidine, 95.0%, 250mg

(R)-1,2,3,4-Tetrahydro-3-isoquinolinecarboxylic acid, 95.0%, 25g

4-Aminomethyl-1-N-Cbz-piperidine hydrochloride, 97.0%, 1g

6-BROMO-5-CYANO-NICOTINIC ACID ETHYL ESTER, 95.0%, 250mg

5-Chloro-6-methyl-2-(pyridin-4-yl)pyrimidin-4-ol, 97.0%, 1g

Filtration unit with SFCA membrane Pore size 0.45 μm, 500 ml, 500 ml, 75 mm, 12 Piece(s)

2-P-TOLYLTHIAZOLE-4-CARBALDEHYDE, 95.0%, 250mg

Propoxybenzene, 97.0%, 5g

Ethyl 6-(4-(5-chloropentanamido)phenyl)-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate, 98%, 1g

Methyl-piperidin-3-ylmethyl-carbamic acid tert-butyl ester, 95.0%, 5g

4-hydroxy-3-nitrosopent-3-en-2-one, ��97.0%, 10g

3,4-Dihydro-2H-benzo[b][1,4]oxazin-6-ol, 95.0%, 100mg

4-Acetyl-1H-pyrrole-2-carboxylic acid, 97.0%, 100mg